The Group has obtained Series A investment of approximately RMB20 million

  • Categories:The development course
  • Author:
  • Origin:
  • Time of issue:2014-01-01 10:42
  • Views:

(Summary description)

The Group has obtained Series A investment of approximately RMB20 million

(Summary description)

  • Categories:The development course
  • Author:
  • Origin:
  • Time of issue:2014-01-01 10:42
  • Views:
Information
The Group has obtained Series A investment of approximately RMB20 million

Scan the QR code to read on your phone

Previous: The GT0918 (Proxalutamide tablets) project has obtained clinical trials permission for prostate cancer indications in China and the United States, and phase I clinical trials have been launched in China
Next: The IND application of the Group's first project, GT0918 (Proxalutamide tablets), has been submitted for prostate cancer indications
Previous: The GT0918 (Proxalutamide tablets) project has obtained clinical trials permission for prostate cancer indications in China and the United States, and phase I clinical trials have been launched in China
Next: The IND application of the Group's first project, GT0918 (Proxalutamide tablets), has been submitted for prostate cancer indications